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Abstract: Metastasis is the main reason for death in breast cancer. Understanding the molecular players in metastasis is crucial for
diagnostic and therapeutic purposes. Notch signalling plays an oncogenic role in breast tumorigenesis and is involved in metastasis.
Downstream mediators of Notch signalling in prometastatic processes are not yet fully discovered. Here we aimed to investigate whether
Notch signalling regulates the expression of SEMA3C, HMGA2, CXCL14, CXCR7, and CCL20, which are involved in prometastatic
processes, in breast cell lines. To this end, expression of the selected genes was analysed following Notch activation by overexpression of
the Notch1 intracellular domain in the normal breast epithelial cell line MCF10A, and inhibition by silencing of the Notch transcriptional
mediator RBPjκ in the breast cancer cell line MDA MB 231. SEMA3C and HMGA2 mRNA were decreased, while CXCL14 and CXCR7
mRNA were increased significantly in response to Notch activation in MCF10A cells. Notch inhibition in MDA MB 231 cells significantly
decreased HMGA2 and CCL20 mRNA. Protein levels were not significantly altered by Notch modulation. In conclusion, we showed that
Notch signalling regulates expression of SEMA3C, CXCL14, CCL20, CXCR7, and HMGA2, which are prominent candidate genes that
might function downstream of Notch to induce prometastatic processes.
Key words: Breast cancer, metastasis, Notch signalling, SEMA3C, HMGA2, CXCL14, CXCR7, CCL20

1. Introduction
Breast cancer is the second most frequently diagnosed
cancer, comprising 25% of all cancer diagnoses worldwide.
Despite improvements in early detection and treatment
approaches, breast cancer is still the leading cause of
cancer-related deaths in women (Ferlay et al., 2013). While
62% of breast cancer cases are localised, 31% have regional
and 6% have distant metastasis at the time of diagnosis.
Five-year survival rates for patients with localised tumours
or tumours with regional metastasis are 98.9% and 85.2%,
respectively. However, the survival rate dramatically falls
to 26.9% for patients with distant metastasis (Howlader et
al., 2017). The main reason for breast-cancer-related deaths
is metastasis, for which there are no effective treatment
approaches. Thus, understanding the key molecular
players in breast cancer metastasis is crucial for diagnostic
and therapeutic purposes.
Notch is an oncogenic signalling pathway involved in
breast cancer. Notch receptors (Notch 1–4 in mammals)
are transmembrane proteins that go through two
subsequent cleavages by gamma-secretase following the
binding of transmembrane ligands (Delta-like ligand
(Dll) 1, 3, 4 and Jagged 1, 2) inserted into the membrane

of the neighbouring cells. The cleavages release the Notch
intracellular domain (NICD), which translocates to the
nucleus and activates its target genes by binding to its
specific mediator, RBPjk, a transcription factor. Notch
4 was first discovered as one of the integration sites of
mouse mammary tumour virus (MMTV), which results in
continuous expression of the Notch4 intracellular domain
and mammary tumour formation (Gallahan and Callahan,
1997). Since then, Notch activation has been shown to
induce cell proliferation and transformation of breast cells,
cause mammary tumour formation in transgenic mouse
models, and correlate with poor prognosis in breast cancer
(Guo et al., 2011).
Notch signalling is involved in the regulation of
epithelial to mesenchymal transition (EMT), migration,
and invasion, which are considered as initial steps of
metastasis (Guo et al., 2011; Espinoza and Miele, 2013).
In different cancer types, including glioma, hepatocellular
carcinoma, and lung and pancreas tumours, Notch
activation induces EMT through transcription factors
Snail-1, Snail-2, and Twist, which are EMT regulators
(Bao et al., 2011; Matsuno et al., 2012; Wang et al., 2012;
Zhang et al., 2012). In breast cancer, several factors such

* Correspondence: ozdenyalcin@iyte.edu.tr

70

This work is licensed under a Creative Commons Attribution 4.0 International License.

KÜÇÜKKÖSE and YALÇIN ÖZUYSAL / Turk J Biol
as radiation, hypoxia, and Klf4 induce EMT, migration,
and invasion via activating Notch receptors (Chen et al.,
2010; McGowan et al., 2011; Xing et al., 2011; Kim et al.,
2016). In contrast, gamma-secretase inhibitors and Numb,
which are negative regulators of Notch signalling, suppress
these processes through inhibition of Notch signalling
(McGowan et al., 2011; Zhang et al., 2016).
Although Notch signalling was shown to interact
with several molecules including TGFβ, IL6/STAT3, and
microRNAs mir4c and mir200c to exert its prometastatic
function, its downstream mediators are not yet fully
discovered (Studebaker et al., 2008; Zhang et al., 2010;
Brabletz et al., 2011; Yang et al., 2011; Hsu et al., 2012; Yu
et al., 2012). In this respect, in order to determine novel
Notch target genes in breast cells, we analysed the list
of genes that were shown to be differentially expressed
in microarray analysis in response to Notch activation
in the normal breast cell line MCF10A (Mazzone et al.,
2010). Among the most significantly altered 1000 genes
we selected 5, SEMA3C, HMGA2, CXCL14, CXCR7, and
CCL20, which are known to be involved in prometastatic
processes but whose interaction with Notch had not been
investigated. Here we aimed to investigate whether Notch
signalling regulates the expression of these genes in breast
cell lines.
2. Materials and methods
2.1. Cell culture and gene expression
The normal breast epithelial cell line MCF10A and the
breast cancer cell line MDA MB 231 were obtained
from ATCC. MCF10A cells were cultured in DMEM/
F12 including HEPES (25 mM), epidermal growth factor
(20 ng/mL), cholera toxin (100 ng/mL), hydrocortisone
(500 ng/mL), 5% horse serum, and insulin (10 µg/mL).
MDA MB 231 cells were cultured in DMEM with 10%
foetal bovine serum. Cells were grown with 5% CO2 at
37 °C. cDNA of the Notch1 intracellular domain (NICD)
was overexpressed by MSCV-NICD retrovirus in order
to activate Notch signalling (Zengin et al., 2015). As
the negative control, empty MSCV virus was used.
shRNA against RBPjk, the mediator of canonical Notch
signalling, was expressed by lentivirus to inhibit Notch
activity (Procopio et al., 2015; Zengin et al., 2015). As the
negative control, shRNA against green fluorescent protein
(GFP) was expressed by lentivirus. Virus preparation and
infection were done as described previously (Zengin et
al., 2015). Briefly, viruses were collected from supernatant
of 293T cells transfected with viral backbone, packaging,
and envelope plasmids. The supernatants that contain the
virus were collected and their titres were checked. Only
the virus preparations that had similar titres were used
for the experiments. All the analyses were done 48 h after
infection.

2.2. RNA isolation and QRT-PCR
Total RNA was isolated with a PureLink RNA Isolation
Kit (Invitrogen), and cDNA synthesis was done using a
RevertAid First Strand cDNA Synthesis Kit (Fermentas).
SYBR Green Master Mix (Fermentas) was used for real-time
RT-PCRs (QRT-PCR) done on an iCycler (Bio-Rad). Three
independent experiments were performed and average
values ± SD (standard deviation) were represented. TATA
box-binding protein (TBP) was used as the endogenous
control gene. Statistical significance was calculated by twotailed Student’s t-test. The primer pairs for each gene were
as follows: CCL20 5’- GTCTGTGTGCGCAAATCCAA
-3’,
5’GACAAGTCCAGTGAGGCACA
-3’;
CXCR7
5’TGTGGGTTACAAAGCTGCCA
-3’,
5’GAGGCGGGCAATCAAATGAC
-3’;
CXCL14
5’AAGGGACCCAAGATCCGCTA
-3’,
5’GACACGCTCTTGGTGGTGAT
-3’;
HEY2
5’-AAGATGCTTCAGGCAACAGG-3’,
5’-GCACTCTCGGAATCCTATGC-3’;
HMGA2
5’GCCCTCTCCTAAGAGACCCA
-3’,
5’CTGCCTCTTGGCCGTTTTTC
-3’;
SEMA3C
5’ACCAAGAGGAATGCGGTCAG
-3’,
5’TGTTGACAAGGCTACGCAGT
-3’;
TBP
5’TAGAAGGCCTTGTGCTCACC
-3’,
5’TCTGCTCTGACTTTAGCACCTG -3’.
2.3. Protein isolation and western blot
RIPA buffer was used for protein isolation. First 20–100 µg
of total protein was run on SDS/PAGE and then transferred
to PVDF membranes. Rabbit anti-Hey2 (1:500, Abcam,
AB184246), rabbit anti-CXCR7 (1:500, Abcam, AB38089),
rat anti-SEMA3C (1:500, Abcam, AB135167), and rabbit
anti-β-actin (1:1000, Abcam, AB75186) were used for
immunoblotting. β-Actin was used for equal loading
control. Quantification of the western blot images was
done with the “Gels” tool of ImageJ. For each independent
experiment, signal intensities of the analysed proteins
were first normalised to β-actin levels for each condition
and then NICD infected samples were normalised to
control infected samples. Then the average values of
three independent experiments were represented for each
protein analysed. Statistical significance was calculated by
two-tailed Student’s t-test.
3. Results
3.1. Effects of Notch activation on the mRNA and protein
expression of candidate genes
MCF10A is a normal breast cell line that does not have
endogenous Notch signalling activity. Notch activation
in MCF10A cells results in transformation demonstrated
by increased colony formation in soft agar and resistance
to apoptosis. Further, MCF10A cells with active Notch
signalling acquired a more elongated mesenchymal-like
phenotype and reduced E-cadherin expression, which
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suggests that Notch activation could induce a prometastatic
phenotype in these cells (Stylianou et al., 2006). Thus, we
selected MCF10A cells to test the effects of Notch activation
on the expression of selected genes. Notch signalling
activation was achieved by overexpression of the Notch1
intracellular domain (NICD) via infection of MCF10A cells
with the virus expressing corresponding cDNA (MSCVNICD). mRNA expression of Notch target gene HEY2 was
increased by more than 200-fold in MSCV-NICD infected
cells compared to control (MSCV) infected cells in 48 h,
showing that Notch signalling activation was successful
(Figure 1). SEMA3C and HMGA2 expression levels
were significantly reduced by 73% and 45%, respectively.
CXCL14 and CXCR7 mRNA levels were significantly
increased by 64- and 5-fold, respectively. CCL20 mRNA
expression was increased by 2.8-fold, which did not reach
statistical significance (Figure 1).
Protein expression levels were analysed by western
blot 48 h after infection of MCF10A cells. Protein levels
of the Notch target gene HEY2 were upregulated around
2-fold, which confirmed activation of Notch signalling in
MCF10A cells (Figure 2). Although CXCR7 protein levels
had a tendency to increase upon Notch activation, we did
not observe a significant change in the protein levels of
either SEMA3C or CXCR7 (Figure 2).
3.2. Effects of Notch inhibition on the mRNA and protein
expression of candidate genes
Notch signalling was inhibited in MDA MB 231 cells,
which have high endogenous Notch activity, by silencing
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4. Discussion
In the present study, we investigated how Notch signalling
activity affects the expression of SEMA3C, HMGA2,
CXCL14, CXCR7, and CCL20 in breast cell lines, in
order to define candidate genes that could be involved in
prometastatic functions of Notch signalling.
SEMA3C, which is a secreted protein that belongs to
class 3 of the semaphorin family, was found in two different
forms, long and short. The long form of SEMA3C induced
migration of breast cancer cell lines MCF7 and MDA
MB 231 in vitro (Esselens et al., 2010; Zhu et al., 2017).
However, in another study, the long form of SEMA3C

SEMA3C

1.2
1

100

RBPjk, the transcriptional mediator of Notch receptors.
Silencing RBPjk (shRBPjk) downregulated the Notch
target gene HEY2 significantly by 81% compared to the
control group (shGFP) (Figure 3). HMGA2 and CCL20
mRNA expression levels were significantly decreased by
36% and 90%, respectively. SEMA3C and CXCR7 mRNA
expression levels were not affected by Notch inhibition,
while CXCL14 mRNA had a tendency to be reduced
but the value did not reach statistically significant levels
(Figure 3).
HEY2 protein levels were reduced by 50% 48 h after
the infection of MDA MB 231 cells with virus expressing
shRNA against RBPjk (Figure 4). In two out of the three
experiments, there was increased signal intensity for CXCR7
protein in response to Notch inhibition; however, the overall
change was not statistically significant (Figure 4).
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Figure 1. mRNA expression levels of the candidate genes in response to Notch activation. Relative mRNA expression levels
of candidate genes and Notch target HEY2 were analysed 48 h after infection of MCF10A cells with control (MSCV) or active
Notch1 receptor expressing virus (MSCV-NICD). Averages of three independent experiments are shown. Error bars represent
standard deviation (P values: *: <0.05, **: <0.0005).
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Figure 2. Protein expression of SEMA3C and CXCR7 in response to Notch activation. Protein expression levels of SEMA3C,
CXCR7, and Notch target gene, HEY2, were analysed 48 h after infection of MCF10A cells with control (MSCV) or active Notch1
receptor expressing virus (MSCV-NICD). Actin was used as equal loading control. Averages of three independent experiments
are shown. Error bars represent standard deviation.

did not affect migration or proliferation of MDA MB 231
cells in vitro. Furthermore, it reduced tumour formation
and metastasis by MDA MB 231 cells in xenograft
mouse models (Mumblat et al., 2015). The decreased
density of blood vessels in these tumours and inhibition
of proliferation and VEGF signalling in endothelial cells
suggest that the in vivo antimetastatic effects of SEMA3C
could be related to reduced angiogenesis. We observed that
SEMA3C mRNA is significantly downregulated by Notch
activation in normal breast epithelial cells. Although
there was no change in SEMA3C protein levels under the
same conditions, this could be explained by the limited
potential of total cell lysates in representing the expression
of secreted proteins. Furthermore, the antibody we used
to detect SEMA3C protein was not able to detect the long
form specifically, which might hinder any possible effect of
Notch activation.
CXCL14, a chemokine, induces proliferation,
migration, and invasion of breast cancer cell lines and was

found to be increased in ductal carcinoma in situ compared
to normal breast tissue, indicating a protumorigenic and
prometastatic role in breast cancer (Allinen et al., 2004;
Pelicano et al., 2009; Rohilla et al., 2015). CCL20, another
chemokine, was also shown to trigger EMT and induce
migration and invasion in MDA MB 231 and primary
mammary epithelial cells (Kim et al., 2009; Marsigliante et
al., 2013, 2016; Muscella et al., 2017). Both of the chemokines
were upregulated at the mRNA level in response to Notch
activation in MFC10A cells and downregulated upon Notch
inhibition in MDA MB 231 cells. These results suggest that
Notch signalling could induce expression of CXCL14 and
CCL20 to mediate its prometastatic effects. Although we
failed to detect protein expression in our total cell lysates
(data not shown), detailed analysis of secreted proteins
could reveal whether the chemokine levels are affected by
Notch signalling and therefore could trigger a paracrine or
autocrine prometastatic process.
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Figure 3. mRNA expression levels of candidate genes in response to Notch inhibition. Relative mRNA expression levels of
candidate genes and Notch target HEY2 were analysed 48 h after infection of MDA MB 231 cells with control virus (shGFP) or
virus expressing shRNA against RBPjk (shRBPjk). Averages of three independent experiments are shown. Error bars represent
standard deviation. (P values: *: <0.0005, **: <0.000005).

Figure 4. CXCR7 protein expression in response to Notch inhibition. CXCR7 and HEY2 proteins were analysed 48 h after
infection of MDA MB 231 cells with control virus (shGFP) or virus expressing shRNA against RBPjk (shRBPjk). Actin
was used as equal loading control. Averages of three independent experiments are shown. Error bars represent standard
deviation (P value: *: <0.002).

CXCR7 is a receptor of CXCL12, which is involved
in breast cancer metastasis via activation of CXCR4.
Overexpression of CXCR7 induces tumorigenesis and
metastasis of breast cancer cell lines in vivo (Miao et al.,
2007), while its inhibition reduces the expressions of MMP2
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and MMP9, which are involved in the invasion of cancer
cells (Gao et al., 2015). However, it has also been shown that
CXCR7 inhibits metastasis by interfering with CXCR4–
CXCL12 interaction and silencing of CXCR7 in endothelial
cells results in recurrence and increased metastasis, pointing
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to a tumour-suppressor role of CXCR7 (Hernandez et
al., 2011; Stacer et al., 2016). In retinoblastoma, silencing
of Notch ligand Jagged-2 resulted in increased CXCR7
expression (Asnaghi et al., 2016). Our results showed that
inhibition of Notch signalling via RBPjκ silencing did not
affect CXCR7 mRNA level, but despite huge variation there
was a tendency towards an increase in CXCR7 protein,
which is parallel to what has been reported previously in
retinoblastoma. However, we also observed a significant
increase in CXCR7 mRNA expression in response to Notch
activation, which also suggests a potential role for CXCR7
in the downstream of Notch activation in normal breast
epithelial cells.
HMGA2 is a nonhistone chromatin-associated protein
involved in transcriptional regulation by interfering with
transcription factor–DNA interaction. In breast cancer, the
presence of HMGA2 mRNA in blood and high expression
in tumours are associated with poor prognosis, late stage,
and increased metastasis risk (Langelotz et al., 2003; Wu et
al., 2016). HMGA2 induces migration and invasion of breast
cancer cell lines via directly regulating Snail-1 expression

(Thuault et al., 2008; Wu et al., 2016). We observed that
HMGA2 mRNA expression is reduced by both activation
and inhibition of Notch signalling in MCF10A and MDA
MB 231 cells, respectively. Our results indicate that direct
regulation of HMGA2 to mediate prometastatic functions
of Notch signalling is unlikely. Rather, HMGA2 expression
might be altered in order to compensate for the effects of
Notch signalling modulation on transcription for the sake
of cell homeostasis.
In conclusion, we showed that Notch signalling
regulates expression of SEMA3C, CXCL14, CCL20, and
CXCR7 to different extents in normal and tumorigenic
breast cell lines. Investigating the functional importance of
this regulation would allow us to understand whether these
genes are playing a role to exert oncogenic or prometastatic
functions of Notch signalling in breast cancer.
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